Browse the corpus

Pulmonary hypertension represents a pathological elevation in pulmonary vascular pressures and resistance, transforming a normally low-pressure circulatory system into one of significant hemodynamic vulnerability. This condition profoundly increases perioperative risk, especially during anesthesia and surgery, where even minor physiological disturbances can precipitate acute right ventricular failure and death. This activity reviews the epidemiology, pathophysiology, and clinical presentation of pulmonary hypertension, highlighting the importance of early recognition and thorough preoperative assessment. Accurate diagnosis, often confirmed by right heart catheterization, and a comprehensive understanding of pulmonary hypertension pathophysiology are essential for optimizing perioperative outcomes. This course explores evidence-based strategies for evaluating and managing patients with pulmonary hypertension in the perioperative setting, as well as induction and maintenance techniques, including opioids, intravenous agents, volatile anesthetics, and ventilation strategies, which minimize hemodynamic instability and support right ventricular function. Through case-based discussion and integration of current guidelines, participants will learn to recognize clinical and hemodynamic indicators of pulmonary hypertension, apply appropriate monitoring techniques, tailor anesthetic and ventilatory management, and collaborate effectively within interprofessional teams. This activity for healthcare professionals is designed to enhance the learner's competence in identifying pulmonary hypertension, performing the recommended evaluation, including risk stratification and pharmacologic optimization, and implementing an appropriate interprofessional approach when managing anesthesia for patients with pulmonary hypertension or right heart failure, ultimately enhancing patient safety, minimizing complications, and improving perioperative outcomes for this high-risk population. Objectives: Assess perioperative risk factors that influence outcomes in patients with pulmonary hypertension. Implement evidence-based anesthetic strategies to optimize right ventricular function and minimize hemodynamic instability. Determine the appropriate pharmacologic anesthetic agents for perioperative application in patients with pulmonary hypertension.

Assess perioperative risk factors that influence outcomes in patients with pulmonary hypertension. Implement evidence-based anesthetic strategies to optimize right ventricular function and minimize hemodynamic instability. Determine the appropriate pharmacologic anesthetic agents for perioperative application in patients with pulmonary hypertension. Collaborate effectively within the interprofessional team to ensure safe, coordinated perioperative care for patients with pulmonary hypertension. Access free multiple choice questions on this topic.

The pulmonary vasculature is typically a low-pressure, low-resistance system that accommodates varying cardiac outputs without significant pressure increases. Pulmonary hypertension represents a pathological increase in pulmonary vascular pressures and resistance, and it significantly elevates perioperative risk for patients undergoing anesthesia and surgery.[1] Pulmonary hypertension is a hemodynamic condition characterized by a mean pulmonary arterial pressure greater than 20 mm Hg at rest, as measured via right heart catheterization, which remains the gold standard for diagnosis.[2][3][4] Pulmonary hypertension can result from multiple pathophysiological mechanisms, including pulmonary arteriolar vasoconstriction, vascular remodeling, thrombotic obstruction, and elevated left heart filling pressures, depending on the underlying cause.[5] Persistent elevation in pulmonary pressures imposes a chronic pressure load on the right ventricle, leading initially to hypertrophy and eventually to right ventricular dilation, dysfunction, and failure. Patients with pulmonary hypertension, particularly those with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, are at high risk of perioperative morbidity and mortality.[1][6] Even mild physiological disturbances during surgery or sedation, eg, tachycardia, hypotension, fluid shifts, or increases in pulmonary vascular resistance, can provoke a pulmonary hypertension crisis, resulting in acute right ventricular decompensation and death.[1][7][8][6] The presence of pulmonary hypertension with or without overt right heart failure increases the risk of numerous complications during the perioperative period, including arrhythmias, myocardial ischemia, right or left heart failure, postoperative respiratory failure, delayed extubation, and prolonged ICU or hospital stay.[7][8] Sedation alone, even without general anesthesia, can also pose significant hemodynamic risk.[1][6]

The presence of pulmonary hypertension with or without overt right heart failure increases the risk of numerous complications during the perioperative period, including arrhythmias, myocardial ischemia, right or left heart failure, postoperative respiratory failure, delayed extubation, and prolonged ICU or hospital stay.[7][8] Sedation alone, even without general anesthesia, can also pose significant hemodynamic risk.[1][6] Effective management requires a thorough understanding of pulmonary hypertension and right ventricular pathophysiology. The anesthesiologist plays a central role in minimizing perioperative risk by maintaining hemodynamic stability, optimizing oxygenation and ventilation, avoiding increases in pulmonary vascular resistance (PVR), and providing effective analgesia. Pharmacologic support with vasopressors or vasodilators may be necessary to balance systemic and pulmonary circulations.[9]

Pulmonary hypertension is a complex, high-risk condition that significantly increases perioperative morbidity and mortality. Management requires a comprehensive understanding of pulmonary vascular pathophysiology, right ventricular function, and the impact of anesthetic and surgical stressors. Optimal care begins with a detailed preoperative evaluation, including history, physical examination, echocardiography, right heart catheterization, and functional assessment, alongside review of pulmonary hypertension-targeted medications such as prostanoids, endothelin receptor antagonists, PDE-5 inhibitors, inhaled nitric oxide, and inhaled treprostinil. In selected patients, interventional procedures such as pulmonary endarterectomy or balloon pulmonary angioplasty can further improve hemodynamics and functional status. Intraoperative management emphasizes meticulous hemodynamic monitoring, lung-protective ventilation, avoidance of abrupt changes in preload or systemic vascular resistance, and maintenance of pulmonary hypertension therapy. Complications—including right ventricular failure, arrhythmias, and hypotension—require rapid, targeted interventions with vasopressors, inotropes, or inhaled vasodilators. Effective care depends on interprofessional collaboration. Anesthesiologists, surgeons, cardiologists, pulmonologists, critical care specialists, and nursing staff must communicate in real-time, coordinate monitoring and pharmacological interventions, and develop contingency plans for the perioperative period. Pharmacists and respiratory therapists ensure appropriate dosing and delivery of pulmonary hypertension-targeted therapies. This collaborative, team-based approach flattens traditional hierarchies, enhances decision-making, reduces complications, and ultimately improves patient outcomes by ensuring safe, individualized care for high-risk patients with pulmonary hypertension.